Merrimack Pharmaceuticals Inc (MACK)
14.68
0.00 (0.00%)
USD |
NASDAQ |
Apr 15, 16:00
14.68
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Cash and Short Term Investments (Quarterly): 18.88M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.88M |
| September 30, 2023 | 18.90M |
| June 30, 2023 | 18.97M |
| March 31, 2023 | 19.40M |
| December 31, 2022 | 19.44M |
| September 30, 2022 | 13.09M |
| June 30, 2022 | 13.36M |
| March 31, 2022 | 14.29M |
| December 31, 2021 | 14.20M |
| September 30, 2021 | 14.56M |
| June 30, 2021 | 14.91M |
| March 31, 2021 | 13.89M |
| December 31, 2020 | 14.04M |
| September 30, 2020 | 15.81M |
| June 30, 2020 | 15.74M |
| March 31, 2020 | 18.02M |
| December 31, 2019 | 16.58M |
| September 30, 2019 | 20.86M |
| June 30, 2019 | 39.90M |
| March 31, 2019 | 58.47M |
| December 31, 2018 | 71.28M |
| September 30, 2018 | 84.85M |
| June 30, 2018 | 60.00M |
| March 31, 2018 | 76.27M |
| December 31, 2017 | 93.44M |
| Date | Value |
|---|---|
| September 30, 2017 | 107.24M |
| June 30, 2017 | 135.50M |
| March 31, 2017 | 17.16M |
| December 31, 2016 | 21.52M |
| September 30, 2016 | 48.47M |
| June 30, 2016 | 82.67M |
| March 31, 2016 | 132.39M |
| December 31, 2015 | 185.61M |
| September 30, 2015 | 62.35M |
| June 30, 2015 | 67.66M |
| March 31, 2015 | 91.77M |
| December 31, 2014 | 124.03M |
| September 30, 2014 | 153.68M |
| June 30, 2014 | 92.75M |
| March 31, 2014 | 124.18M |
| December 31, 2013 | 155.20M |
| September 30, 2013 | 182.48M |
| June 30, 2013 | 62.14M |
| March 31, 2013 | 86.69M |
| December 31, 2012 | 109.95M |
| September 30, 2012 | 86.67M |
| June 30, 2012 | 106.71M |
| March 31, 2012 | 30.56M |
| December 31, 2011 | 50.45M |
| September 30, 2011 | 59.23M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.09M
Minimum
Sep 2022
39.90M
Maximum
Jun 2019
17.62M
Average
15.81M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 23.18M |
| Ampio Pharmaceuticals Inc | 4.089M |